Filing Details

Accession Number:
0001104659-22-072059
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-16 21:27:23
Reporting Period:
2022-06-15
Accepted Time:
2022-06-16 21:27:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Altimmune Inc. ALT Pharmaceutical Preparations (2834) 202726770
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1428764 David Drutz C/O Altimmune, Inc.,
910 Clopper Road, Suite 201S
Gaithersburg MD 20878
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Acquisiton 2022-06-15 1,000 $8.00 20,012 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.0001 333 Indirect See Footnote
Footnotes
  1. Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.